이은혜

이은혜 is a declared insider of 넥스트바이오메디컬, with filings sourced from DART (FSS). Between 20 August 2024 and 3 December 2025, the trades on record add up to 4 filings.

In open-market terms, that means 3 purchases on one side and 1 sale on the other. The totals exclude 4 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2025 alone, the filings show 1 purchase and 1 sale.

On 3 December 2025 came the latest disclosure, an open-market sale in 넥스트바이오메디컬. The latest purchase dates back some time: it was published 376 days ago, on 30 October 2025. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.